These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2902012)

  • 1. Mutants of Actinomyces viscosus T14V lacking type 1, type 2, or both types of fimbriae.
    Cisar JO; Vatter AE; Clark WB; Curl SH; Hurst-Calderone S; Sandberg AL
    Infect Immun; 1988 Nov; 56(11):2984-9. PubMed ID: 2902012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of adherence of Actinomyces naeslundii (Actinomyces viscosus) T14V-J1 to saliva-treated hydroxyapatite by a monoclonal antibody to type 1 fimbriae.
    Nesbitt WE; Beem JE; Leung KP; Stroup S; Swift R; McArthur WP; Clark WB
    Oral Microbiol Immunol; 1996 Feb; 11(1):51-8. PubMed ID: 8604255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific absence of type 2 fimbriae on a coaggregation-defective mutant of Actinomyces viscosus T14V.
    Cisar JO; Curl SH; Kolenbrander PE; Vatter AE
    Infect Immun; 1983 May; 40(2):759-65. PubMed ID: 6132880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against the Ag2 fimbriae of Actinomyces viscosus T14V inhibit lactose-sensitive bacterial adherence.
    Revis GJ; Vatter AE; Crowle AJ; Cisar JO
    Infect Immun; 1982 Jun; 36(3):1217-22. PubMed ID: 6124506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of bacterial adhesion in the oral cavity.
    Mergenhagen SE; Sandberg AL; Chassy BM; Brennan MJ; Yeung MK; Donkersloot JA; Cisar JO
    Rev Infect Dis; 1987; 9 Suppl 5():S467-74. PubMed ID: 2891180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of surface fimbriae (fibrils) in the adsorption of Actinomyces species to saliva-treated hydroxyapatite surfaces.
    Clark WB; Webb EL; Wheeler TT; Fischlschweiger W; Birdsell DC; Mansheim BJ
    Infect Immun; 1981 Sep; 33(3):908-17. PubMed ID: 6169645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical and functional studies of Actinomyces viscosus T14V type 1 fimbriae with monoclonal and polyclonal antibodies directed against the fimbrial subunit.
    Cisar JO; Barsumian EL; Siraganian RP; Clark WB; Yeung MK; Hsu SD; Curl SH; Vatter AE; Sandberg AL
    J Gen Microbiol; 1991 Aug; 137(8):1971-9. PubMed ID: 1683401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of adsorption of Actinomyces viscosus T14V to saliva-treated hydroxyapatite by antibody against type 1 fimbriae.
    Clark WB; Wheeler TT; Cisar JO
    Infect Immun; 1984 Feb; 43(2):497-501. PubMed ID: 6141143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of Actinomyces viscosus mutants defective in binding salivary proline-rich proteins.
    Nesbitt WE; Beem JE; Leung KP; Clark WB
    Infect Immun; 1992 Mar; 60(3):1095-100. PubMed ID: 1347286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 fimbrial lectin-mediated phagocytosis of oral Actinomyces spp. by polymorphonuclear leukocytes.
    Sandberg AL; Mudrick LL; Cisar JO; Brennan MJ; Mergenhagen SE; Vatter AE
    Infect Immun; 1986 Nov; 54(2):472-6. PubMed ID: 2876961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fimbria-specific antibodies in serum and saliva of mice immunized with Actinomyces viscosus T14V fimbriae.
    Crawford PC; Clark WB
    Infect Immun; 1986 Nov; 54(2):507-15. PubMed ID: 2876962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and expression of a type 1 fimbrial subunit of Actinomyces viscosus T14V.
    Yeung MK; Chassy BM; Cisar JO
    J Bacteriol; 1987 Apr; 169(4):1678-83. PubMed ID: 2881922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study on biological properties of fimbriae of A. viscosus. III. Adherence activity of fimbriae of A. viscosus].
    Liu T; Li W; Yue S
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 May; 17(2):169-72. PubMed ID: 12539718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actinomyces adsorption mediated by type-1 fimbriae.
    Clark WB; Wheeler TT; Lane MD; Cisar JO
    J Dent Res; 1986 Sep; 65(9):1166-8. PubMed ID: 2874164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exclusive presence of lactose-sensitive fimbriae on a typical strain (WVU45) of Actinomyces naeslundii.
    Cisar JO; David VA; Curl SH; Vatter AE
    Infect Immun; 1984 Nov; 46(2):453-8. PubMed ID: 6150007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservation of an Actinomyces viscosus T14V type 1 fimbrial subunit homolog among divergent groups of Actinomyces spp.
    Yeung MK
    Infect Immun; 1992 Mar; 60(3):1047-54. PubMed ID: 1347285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and use of integration plasmids to generate site-specific mutations in the Actinomyces viscosus T14V chromosome.
    Yeung MK
    Infect Immun; 1995 Aug; 63(8):2924-30. PubMed ID: 7622214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and function of Actinomyces naeslundii T14V type 1 fimbriae require the expression of additional fimbria-associated genes.
    Yeung MK; Ragsdale PA
    Infect Immun; 1997 Jul; 65(7):2629-39. PubMed ID: 9199430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a 95 kDa putative adhesin from Actinomyces serovar WVA963 strain PK1259 that is distinct from type 2 fimbrial subunits.
    Klier CM; Kolenbrander PE; Roble AG; Marco ML; Cross S; Handley PS
    Microbiology (Reading); 1997 Mar; 143 ( Pt 3)():835-846. PubMed ID: 9084167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and localization of a lectin on Actinomyces viscosus T14V by monoclonal antibodies.
    Cisar JO; Barsumian EL; Curl SH; Vatter AE; Sandberg AL; Siraganian RP
    J Immunol; 1981 Oct; 127(4):1318-22. PubMed ID: 6115881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.